Humana
$388.36Change from previous close: +2.29%Absolute change: +$8.68
At a glance
- Revenue growth
- +10.11%
- 2025 vs 2024
- Net income growth
- −1.57%
- 2025 vs 2024
- Net margin
- 0.9%
- 2024: 1.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 40,867 | 39,648 | 32,515 | 32,649 | 32,388 | — |
| EBIT | 1,149 | 1,788 | -865 | 302 | 898 | — |
| Interest expense | 197 | 193 | 146 | 168 | 157 | — |
| Pre-tax income | 952 | 1,595 | -1,011 | 134 | 741 | — |
| Income tax | 238 | 395 | -249 | -86.0 | 179 | — |
| Net income | 694 | 1,186 | -796 | 195 | 545 | — |
| Net income to common shareholders | 694 | 1,186 | -796 | 195 | 545 | — |
| Basic EPS | 5.78 | 9.85 | — | 1.62 | 4.52 | 10.31 |
| Diluted EPS | 5.73 | 9.83 | — | 1.62 | 4.51 | 10.30 |
| Average shares (basic) | 120 | 120 | — | 120 | 121 | 121 |
| Average shares (diluted) | 121 | 121 | — | 121 | 121 | 121 |